{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Search results for angiotensin root_notes_note in Note (approximate match)
Status:
Possibly Marketed Outside US
Source:
21 CFR 333
(1998)
Source URL:
First approved in 1998
Source:
21 CFR 333
Source URL:
Class (Stereo):
CHEMICAL (ACHIRAL)
Status:
US Approved Rx
(1965)
Source:
BLA101995
(1965)
Source URL:
First approved in 1965
Source:
BLA101995
Source URL:
Class:
MIXTURE
Status:
Investigational
Source:
USAN:IPROCINODINE HYDROCHLORIDE [USAN]
Source URL:
Class:
MIXTURE
IPROCINODINE, a semisynthetic antibiotic, is a mixture of the isopropylated cinodine I and cinodide II, glycolipid antibiotics isolated from Nocardia species.
Status:
Investigational
Source:
USAN:CINODINE HYDROCHLORIDE [USAN]
Source URL:
Class:
MIXTURE
Status:
Other
Class:
MIXTURE
Status:
Other
Class:
MIXTURE
Status:
Other
Class:
MIXTURE
Status:
Other
Class:
MIXTURE
Status:
Possibly Marketed Outside US
Source:
NCT04286503: Phase 4 Interventional Unknown status Novel Coronavirus Infectious Disease (COVID-19)
(2020)
Source URL:
Class:
MIXTURE
